Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis - PubMed (original) (raw)

Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis

S Hammarström et al. Proc Natl Acad Sci U S A. 1975 Dec.

Abstract

Lesional epidermis of psoriasis has a probable reduction in the cyclic AMP/cyclic GMP ratio. This altered ratio may in part be responsible for the characteristic glycogen storage, rapid cell proliferation, and reduced differentiation in lesional epidermis. The concentrations of prostaglandins E2 and F2alpha, free arachidonic acid, and 12L-hydroxy-5,8,10,14-eicosatetrawnoic acid in specimens of uninvolved and involved epidermis of psoriasis were measured with deuterium-labeled carriers and multiple ion analysis. Snap frozen specimens contained: 1.4 +/- 0.4 mug/g (wet weight) of arachidonic acid in uninvolved in contrast to 36.3 +/- 16.7 mug/g in involved epidermis (P = 0.015); less than 0.05 +/- 0.01 mug/g of hydroxyeicosatetraenoic acid in uninvolved in contrast to 4.1 +/- 1.9 mug/g in involved epidermis (P = 0.015); 23.6 +/- 5.0 ng/g of prostaglandin E2 in uninvolved in contrast to 33.1 +/- 5.7 ng/g in involved epidermis (P less than 0.01); and 21.0 +/- 4.4 ng/g of prostaglandin F2alpha in uninvolved in contrast to 39.0 +/- 5.9 ng/g in involved epidermis (P less than 0.01). The arachidonic acid and hydroxyeicosatetraenoic acid levels in involved epidermis were strongly correlated (r = 0.97). The increased levels of arachidonic acid and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid in involved epidermis may have diagnostic and pathophysiological importance.

PubMed Disclaimer

Cited by

Signaling pathways and targeted therapies for psoriasis.
Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Guo J, et al. Signal Transduct Target Ther. 2023 Nov 27;8(1):437. doi: 10.1038/s41392-023-01655-6. Signal Transduct Target Ther. 2023. PMID: 38008779 Free PMC article. Review.
Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles.
Tiucă OM, Morariu SH, Mariean CR, Tiucă RA, Nicolescu AC, Cotoi OS. Tiucă OM, et al. Healthcare (Basel). 2023 Jun 26;11(13):1849. doi: 10.3390/healthcare11131849. Healthcare (Basel). 2023. PMID: 37444683 Free PMC article. Review.
Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy.
Sarandi E, Krueger-Krasagakis S, Tsoukalas D, Sidiropoulou P, Evangelou G, Sifaki M, Rudofsky G, Drakoulis N, Tsatsakis A. Sarandi E, et al. Front Mol Biosci. 2023 Jun 19;10:1201912. doi: 10.3389/fmolb.2023.1201912. eCollection 2023. Front Mol Biosci. 2023. PMID: 37405259 Free PMC article. Review.
Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
Zhan YP, Chen BS. Zhan YP, et al. Int J Mol Sci. 2023 Jun 12;24(12):10033. doi: 10.3390/ijms241210033. Int J Mol Sci. 2023. PMID: 37373186 Free PMC article.
Multiscale molecular dynamics simulations predict arachidonic acid binding sites in human ASIC1a and ASIC3 transmembrane domains.
Ananchenko A, Musgaard M. Ananchenko A, et al. J Gen Physiol. 2023 Mar 6;155(3):e202213259. doi: 10.1085/jgp.202213259. Epub 2023 Jan 10. J Gen Physiol. 2023. PMID: 36625864 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1974 Oct;71(10):3824-8 - PubMed
1. Biochim Biophys Acta. 1968 Oct 22;164(2):426-9 - PubMed
1. J Invest Dermatol. 1975 Jul;65(1):179-90 - PubMed
1. J Invest Dermatol. 1975 Oct;65(4):375-8 - PubMed
1. Anal Biochem. 1973 Aug;54(2):434-53 - PubMed

Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis - PubMed (original) (raw)